•20-Year Mortality in a Population-Based Cohort of Patients with Inflammatory Bowel Disease from New Zealand
•Health-related quality of life outcomes among vedolizumab-treated patients with inflammatory bowel disease in the UK and Ireland: a 52-week observational study (OCTAVO)
•Design and Synthesis of Novel sEH Inhibitors for the Treatment of Inflammatory Bowel Disease
•EXPRESS: Impact of Anxiety and Depression on Hospitalization Outcomes and Healthcare Costs in Ulcerative Colitis & Crohn's Disease: A National Inpatient Sample Analysis
•Editorial: Current trends and future management of IBD, volume II